Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07387991 · ClinicalTrials.gov registry record · NA

Evaluating the Ability of a Multi-Strain Postbiotic to Impact Inflammation, Immune Components, Gastrointestinal Symptoms, Recovery, Anxiety, and Intestinal Permeability

A NA study, sponsored by Lindenwood University.

Not yet
Registry status
NA
Development phase
50
Enrollment target

NCT07387991 is a NA study that has not yet begun recruiting, run by Lindenwood University. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07387991, a NA study, has not yet begun recruiting, sponsored by Lindenwood University.

NOT YET RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

This study will evaluate the effects of a multi-strain postbiotic supplement on markers of inflammation, immune function, gastrointestinal symptoms, psychological well-being, and intestinal permeability in healthy adults. The primary objective is to determine whether four weeks of postbiotic supplementation alters physiological and perceptual responses to a standardized bout of moderate-to-high intensity exercise compared with placebo. Approximately 50 healthy men and women aged 18 to 55 years will be enrolled in a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Participants will be randomly assigned to receive either a multi-strain postbiotic supplement or a matched placebo for 28 days. At the end of the supplementation period, participants will complete a 45-minute treadmill exercise bout at 75% of their individually determined maximum heart rate. Blood samples will be collected to assess biomarkers of inflammation, immune activity, and recovery. Gastrointestinal symptoms, intestinal permeability, anxiety, and perceived recovery will be evaluated using validated questionnaires. This study is designed to determine whether postbiotic supplementation modulates physiological stress responses and subjective well-being following prolonged exercise in healthy adults.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Multi-Strain Postbiotic

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-06-01
Est. Completion 2027-06-01
Phase NA

Sponsor

Lindenwood University

29 total trials

What the Registry Record Tells You About NCT07387991

The ClinicalTrials.gov registry entry for NCT07387991 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindenwood University, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT07387991 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07387991 about?

NCT07387991 is a clinical study titled "Evaluating the Ability of a Multi-Strain Postbiotic to Impact Inflammation, Immune Components, Gastrointestinal Symptoms, Recovery, Anxiety, and Intestinal Permeability". This study will evaluate the effects of a multi-strain postbiotic supplement on markers of inflammation, immune function, gastrointestinal symptoms, psychological well-being, and intestinal permeability in healthy adults. The primary objective is to determine whether four weeks of postbiotic supplem...

What is the current status of trial NCT07387991?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-06-01. Estimated completion is 2027-06-01.

What interventions are being tested in trial NCT07387991?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Multi-Strain Postbiotic (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07387991?

This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.